As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...

Deloitte’s patient engagement platform suite ConvergeHealth on Feb. 18 launched a new digital platform on Amazon Web Services that connects patients and investigators with clinical research trials.

Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities. Launched in ...

BOWIE, Md.--(BUSINESS WIRE)--Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the launch of Clinical Research Patient Finder, an ...

| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...

The AI platform goes through unstructured medical records to surface eligible trials, allowing clinical research teams to ...

Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology The field of rare cancer research is rapidly transforming, marked by significant ...

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence-based Clinical Trial Solutions for Patient Matching - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering ...

What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation is currently conducting a study titled ‘Feasibility of ...

NEO100-01, an intranasal perillyl alcohol therapy, targets IDH1-mutant astrocytomas, aiming to bypass the blood-brain barrier. The phase 2a trial is nearing full enrollment, conducted at seven U.S.